ライフサイエンスコーパス: phosphate-buffered

1 line, 0.12% chlorhexidine gluconate, or 0.1% phosphate-buffered chlorine dioxide mouthwash for 1 minu

2 trodeposition of cobalt oxide materials from phosphate-buffered electrolyte solutions.

3 ion from 20 to 120 nM in high ionic strength phosphate-buffered fluoride (PBF) buffer, yielding a lim

4 of one fixative and buffer type (10% neutral phosphate-buffered formalin, pH 7) for FFPE tissue acros

5 iations: ANOVA = analysis of variance, PBS = phosphate-buffered physiological saline solution, TMJ =

6 LAD (100 microg/mouse intraperitoneally), or phosphate buffered saline (100 microl/mouse intraperiton

7 Mice were treated with phosphate buffered saline (as vehicle control), dexameth

8 controlling the concentration of Dulbecco's phosphate buffered saline (DPBS) electrolyte, the double

9 The models were exposed to phosphate buffered saline (negative control), triethylen

10 ravenous injection of (n=10/group): Group 1: phosphate buffered saline (PBS 1 ml) for control.

11 r injections (50 microl/injection) of either phosphate buffered saline (PBS) (n = 9), human synoviocy

12 bilized antibodies on the ZnO surface in (i) phosphate buffered saline (PBS) and (ii) human serum.

13 Detection of cTnT in phosphate buffered saline (PBS) and human serum (HS) buf

14 anging from ~10(5) to 3.2 x 10(7) CFUs/mL in phosphate buffered saline (PBS) and peritoneal dialysis

15 e lateral motion with synovial fluid (SF) or phosphate buffered saline (PBS) as lubricant.

16 hest Q approximately 9300 in the bio-ambient phosphate buffered saline (PBS) as well as highest sensi

17 either Freund's incomplete adjuvant (IFA) or phosphate buffered saline (PBS) at monthly intervals.

18 rene (d(8)-PS) and SiO(2) model surfaces and phosphate buffered saline (PBS) at pH 7.4.

19 ns, and was found to be slowly degradable in phosphate buffered saline (PBS) but more rapidly degrade

20 ound to contain higher TPC, TFC and TCC than phosphate buffered saline (PBS) extracts for all the fru

21 particle loaded gels can release timolol in phosphate buffered saline (PBS) for about a month at roo

22 g was induced in one eye with glutaraldehyde/phosphate buffered saline (PBS) immersion while the othe

23 Incubation of the coated sensors in phosphate buffered saline (PBS) led to a monotonic incre

24 t between phospholipid bilayer membranes and phosphate buffered saline (PBS) medium (DMW,PBS) for 19

25 DF-1) versus a bolus application of SDF-1 in phosphate buffered saline (PBS) on wound healing was eva

26 re injected subcutaneously with bleomycin or phosphate buffered saline (PBS) once daily for 28 days.

27 tions of physiologic ionic strength, such as phosphate buffered saline (PBS) or 150 mM KCl.

28 pended inside a flowing medium that contains phosphate buffered saline (PBS) or whole blood.

29 lly captured and detected HIV-1 in serum and phosphate buffered saline (PBS) samples with viral loads

30 mplification at room temperature in 30min in phosphate buffered saline (PBS) solution.

31 ther with fibrocytes, dermal fibroblasts, or phosphate buffered saline (PBS) through tail vein inject

32 , we explore the effect of concentration for phosphate buffered saline (PBS), a typical ionic medium

33 anotubes were found not only to be stable to phosphate buffered saline (PBS), serum, and a variety of

34 ch resonances show high Q in the bio-ambient phosphate buffered saline (PBS).

35 lized on a gold film in both air and flowing phosphate buffered saline (PBS).

36 ol mice were similarly injected with sterile phosphate buffered saline (PBS).

37 a control vector with no insert (AxCANI), or phosphate buffered saline (PBS).

38 performed in physiological buffers, such as phosphate buffered saline (PBS).

39 R) at a diffusion-controlled rate in aerated phosphate buffered saline (PBS).

40 The films were shown to be stable in phosphate buffered saline (PBS).

41 ere performed at 37 degrees C in rat plasma, phosphate buffered saline (PBS, pH 7.4) and PB (pH 7.4).

42 release of 23% and 47% bound lactic acid in phosphate buffered saline (PBS, pH7.4) and acetate buffe

43 raarticular injections (50 mul/injection) of phosphate buffered saline (PBS; n = 14 rats) and human s

44 and their critical micelle concentrations in phosphate buffered saline (pH 7.4) are </=85 microg/mL.

45 ately as Hg sources in washed cell assays in phosphate buffered saline (pH 7.4), we report how cell-m

46 in vivo compared to in vitro using agitated phosphate buffered saline +0.02% Tween 80 pH7.4, includi

47 The reaction was efficient in phosphate buffered saline and a wide range of biological

48 We have calibrated the sensor using phosphate buffered saline and demonstrated trace detecti

49 and interlaboratory measurements, samples of phosphate buffered saline and urine, spiked with differe

50 nose-6-Phosphate (29 animals), or 100 mul of phosphate buffered saline as a placebo control (29 anima

51 obular proteins, such as hen egg lysozyme in phosphate buffered saline at room temperature, lose nati

52 approximately 5fg/ml for assays conducted in phosphate buffered saline buffer (PBS) and approximately

53 ology and immunohistochemistry, the other in phosphate buffered saline for flow cytometry.

54 nhancer of viral infection fibrils formed in phosphate buffered saline keep evolving after the initia

55 In phosphate buffered saline medium the actual lipophilicit

56 e arthritis compared with mice injected with phosphate buffered saline or control antibodies.

57 ysis using a short gel-filtration column and phosphate buffered saline solution as the mobile phase.

58 , Neq)> decreased from approximately 0.24 in phosphate buffered saline to 0.12 in 3,300 mug/ml HA and

59 th a 15% solution of saponin and washed with phosphate buffered saline to release intact parasites.

60 after the surgical induction of OA, LUB:1 or phosphate buffered saline vehicle was administered by in

61 -I, anti-IFN-I, isotype control antibody, or phosphate buffered saline was administered to C57BL/6 an

62 unction studies, recombinant IL-7 or control phosphate buffered saline was injected intraperitoneally

63 SEB dissolved in phosphate buffered saline was resolved to levels as low

64 LV-1h153 (1 x 10(7) plaque-forming units) or phosphate buffered saline was tested in an orthotopic mu

65 Given time, most of the assemblies in phosphate buffered saline will turn into elongated thin

66 ol virus without insert, or control vehicle (phosphate buffered saline) intraarticularly before arthr

67 Competition experiments (in 68% DMSO/phosphate buffered saline) using 1 equiv of N-phenethyl-

68 obtained compared to result obtained in PBS (phosphate buffered saline).

69 .0078mg/ml of T24 (Grade III) cell lysate in phosphate buffered saline, artificial urine and human ur

70 cross-sections of brushite cylinders aged in Phosphate Buffered Saline, Foetal Bovine Serum, Dulbecco

71 xhibited excellent analytical performance in phosphate buffered saline, including a NO sensitivity of

72 te in HCG-treated mice compared with that in phosphate buffered saline-treated mice.

73 3-treated P. gingivalis-infected mice versus phosphate buffered saline-treated P. gingivalis-infected

74 tection limit of 500 muM in water and 1mM in phosphate buffered saline.

75 specific and little non-specific binding in phosphate buffered saline.

76 via a sandwich immunoassay for human IgG in phosphate buffered saline.

77 25 head and neck squamous carcinoma cells in phosphate buffered saline.

78 Outflow facility for phosphate-buffered saline (0.0027 +/- 0.00036 muL/min/mm

79 em of acellular agarose disks and dextran in phosphate-buffered saline (3 and 70 kDa).

80 . cenocepacia strain BC7 suspended in either phosphate-buffered saline (BC7/PBS) or P. aeruginosa alg

81 l suspension of liposomes coated with either phosphate-buffered saline (control) or clodronate (a mac

82 oom temperature for 4h in human plasma or in phosphate-buffered saline (control).

83 s, eyes received 5 microL of either Dulbecco phosphate-buffered saline (D-PBS), 10 microM D9R, or 100

84 bacterial endotoxin contained in Dulbecco's phosphate-buffered saline (DPBS), a cohesive OVD, and a

85 c adenocarcinoma cell line Pan02 (cancer) or phosphate-buffered saline (healthy).

86 cells at room temperature or 4 degrees C in phosphate-buffered saline (labeling efficiency range, 13

87 imits ranging from 1 to 40 pg in 6 muL of 1x phosphate-buffered saline (PBS) (0.2-6 ng/mL) were achie

88 In the presence of 5 mM glucose in phosphate-buffered saline (PBS) (50 mM phosphate buffer

89 d in 50 mg/mL TCN solution (experimental) or phosphate-buffered saline (PBS) (control).

90 of transduced human MSCs suspended in either phosphate-buffered saline (PBS) (n = 4) or matrigel (n =

91 y with buffers A, B, and C, or separately by phosphate-buffered saline (PBS) alone.

92 n of the brain with cold or room temperature phosphate-buffered saline (PBS) also caused significant

93 d -25 degrees C for at least 3 days by using phosphate-buffered saline (PBS) and cysteine/methionine-

94 The detection curves were obtained in phosphate-buffered saline (PBS) and in undiluted artific

95 ts/mouse), lipopolysaccharide (2 microg), or phosphate-buffered saline (PBS) and sacrificed mice 24 h

96 niae were treated intravenously with PFCE or phosphate-buffered saline (PBS) and then managed in eith

97 tal recoveries obtained for all compounds in phosphate-buffered saline (PBS) and urine samples owing

98 jected intravenously with 3 x 10(6) hMSCs or phosphate-buffered saline (PBS) at 1 day after MCAo.

99 HDP-cyclic-CDV was suspended in phosphate-buffered saline (PBS) at 37 degrees C and form

100 es for the detection of nitric oxide (NO) in phosphate-buffered saline (PBS) at pH 7.4.

101 were injected with cultured mast cells or 1x phosphate-buffered saline (PBS) before collecting serum,

102 to ovalbumin (OVA-psigma1), psigma1 only, or phosphate-buffered saline (PBS) before oral challenge wi

103 pSHEV-1 triple mutant, wild-type pSHEV-3, or phosphate-buffered saline (PBS) buffer (n = 10).

104 CA15-3 detection was first characterized in phosphate-buffered saline (PBS) buffer and in fetal calf

105 Hydrolysis in pH 5.5 Mes and pH 7.2 phosphate-buffered saline (PBS) buffers was similar, but

106 Phosphate-buffered saline (PBS) containing celecoxib-PLG

107 In phosphate-buffered saline (PBS) containing EDTA, the apo

108 -2-infected guinea pigs compared to those of phosphate-buffered saline (PBS) control-vaccinated anima

109 ear in WT-infected mice did not differ from phosphate-buffered saline (PBS) controls or mice infecte

110 g) were randomly divided into three groups: phosphate-buffered saline (PBS) controls, PRARI controls

111 A plus Vaxfectin i.m. or 100 mug of DNA plus phosphate-buffered saline (PBS) i.m. using a needleless

112 in the presence of succinate, fumarate, and phosphate-buffered saline (PBS) in different cell models

113 Finally, experiments with phosphate-buffered saline (PBS) indicate that the films

114 rfusion of Adv.cmv.L-CPT1 (L-CPT1, n=15) vs. phosphate-buffered saline (PBS) infusion (PBS, n=7) or e

115 technique for cell-free virus elution using phosphate-buffered saline (PBS) may provide an alternati

116 p was intravenously injected either with 2mL phosphate-buffered saline (PBS) or 3million hUTC in PBS

117 animals used as controls were injected with phosphate-buffered saline (PBS) or GBV-B, respectively.

118 olar lavage fluids from mice inoculated with phosphate-buffered saline (PBS) or S. aureus were deplet

119 ue-Dawley rats, 2 microg rhTSG-6 in 5-microL phosphate-buffered saline (PBS) or the same volume of on

120 th a S-OIV clinical isolate concentration in phosphate-buffered saline (PBS) over a range of 18-1.8 x

121 The LK14 peptide, adsorbed from a pH 7.4 phosphate-buffered saline (PBS) solution, displayed very

122 rythrocytes at 37 degrees C for up to 24h in phosphate-buffered saline (PBS) supplemented with 0 to 5

123 lity to recover DNA from Brucella species in phosphate-buffered saline (PBS) suspension and from spik

124 plification was achieved through dilution of phosphate-buffered saline (PBS) to tune Cdl to dominate

125 he appearance of tumor growth, compared with phosphate-buffered saline (PBS) treatment, but had no ef

126 Biliverdin (40 mg/kg) or phosphate-buffered saline (PBS) was administered either

127 As an internal control, phosphate-buffered saline (PBS) was similarly injected o

128 to 400 mg/dL or 0.10-10.34 mmol/L in 100 mM phosphate-buffered saline (PBS) without significant inte

129 Inhibition of alpha-toxin by phosphate-buffered saline (PBS), 0.1% methyl-beta-cyclod

130 Phosphate-buffered saline (PBS), 5x10(5) CD34+ cells/kg,

131 x 10(9) plaque-forming units of AdvBcl-2 in phosphate-buffered saline (PBS), AdvNull empty vector in

132 (PPSV23; Merck, Whitehouse Station, NJ), or phosphate-buffered saline (PBS), before corneal infectio

133 Compared with chronic infusions of phosphate-buffered saline (PBS), LPS infusions produced

134 reserved in diverse sample matrices, namely, phosphate-buffered saline (PBS), Middlebrook 7H9 medium

135 tion (BDL) for 14 days and were treated with phosphate-buffered saline (PBS), UDCA, all-trans retinoi

136 were attained for all the studied probes in phosphate-buffered saline (PBS), urine, and whole blood.

137 n mice that received the vaccine compared to phosphate-buffered saline (PBS)- and vector-treated cont

138 Here we report that a phosphate-buffered saline (PBS)-based nucleofection meth

139 lae were found in their spleens, unlike with phosphate-buffered saline (PBS)-dosed mice, and vaccinat

140 e exhibited a dermal architecture similar to phosphate-buffered saline (PBS)-injected control and nor

141 as 2.5-fold higher than in the contralateral phosphate-buffered saline (PBS)-injected eye (n = 6 rats

142 r 50 mg/kg per week), nontarget (NT) ASO, or phosphate-buffered saline (PBS).

143 ol mice were similarly injected with sterile phosphate-buffered saline (PBS).

144 oneal injection of either 5 g/kg of rhTrx or phosphate-buffered saline (PBS).

145 1% apoEdp, 1% trifluorothymidine (TFT), and phosphate-buffered saline (PBS).

146 njunctival injections of either ilomastat or phosphate-buffered saline (PBS).

147 ferritin Ab-functionalized microparticles in phosphate-buffered saline (PBS).

148 tions of VIPhyb (peptidic VIP-antagonist) or phosphate-buffered saline (PBS).

149 injection of 1 million human fibroblasts in phosphate-buffered saline (PBS); group 2, intravenous in

150 Phosphate-buffered saline (PBS, control, n=7) or 3x10(6)

151 obiota in two frequently used batch systems: phosphate-buffered saline (PBS, oligotrophic) and basal

152 ted 24 hours after intravitreal injection of phosphate-buffered saline (PBS, vehicle) or PBS + ouabai

153 ed daily intraperitoneal injections of TM or phosphate-buffered saline (PBS; control) through P17.

154 beta2-treated group), fetal calf serum (FCS)/phosphate-buffered saline (PBS; FCS/PBS-treated control

155 Control animals received phosphate-buffered saline (PBS; n = 5 to 7).

156 easured values for glucose concentrations in phosphate-buffered saline (pH approximately 7.4) based o

157 usion of either human recombinant decorin or phosphate-buffered saline (vehicle).

158 Myocardial retention of cells suspended in phosphate-buffered saline 1 h after delivery was 17.6 +/

159 BALB/c mice received LAIV or phosphate-buffered saline 1 or 7 days before or during p

160 d pigs (n = 130) in one of four groups (PRCV/phosphate-buffered saline [PBS] [n = 41], PRCV/DEX [n =

161 RMG (but not in those vaccinated with REG or phosphate-buffered saline [PBS]) after homologous or het

162 erate, and severe asthma were processed with phosphate-buffered saline and assayed for eotaxin by ELI

163 d 2-[(131) I] exhibit good stability in both phosphate-buffered saline and blood serum.

164 t IL-22 or anti-IL-22 neutralizing antibody; phosphate-buffered saline and IgG served as respective c

165 ntly enhanced analytical performance in both phosphate-buffered saline and plasma (6-20x improvement

166 4.5 and 7.2, (2) physiologic salt solutions (phosphate-buffered saline and saline) commonly used for

167 ated mice compared to those in animals given phosphate-buffered saline and then infected with the bac

168 thod is approximately 1 IU/mL (2 nM) in both phosphate-buffered saline and urine samples, and only 0.

169 pyridine analogues were more soluble in both phosphate-buffered saline and water.

170 lated with herpes simplex virus 1 (HSV-1) or phosphate-buffered saline as a control.

171 determinations were lower in both saline and phosphate-buffered saline as compared to vaginal fluid m

172 Ten pigs in group 1 received phosphate-buffered saline as negative controls.

173 dies of Abeta(1-40) amyloid fibrils grown in phosphate-buffered saline at 37 degrees C under unstirre

174 Release studies were conducted in phosphate-buffered saline at 37 degrees C with continuou

175 Release studies were conducted in phosphate-buffered saline at 37 degrees C with continuou

176 formed soluble aggregates upon dilution into phosphate-buffered saline at 37 degrees C.

177 or A beta(1-40) amyloid fibril elongation in phosphate-buffered saline at 37 degrees C.

178 ells were formed into pellets and covered in phosphate-buffered saline at room temperature for 56 h.

179 of 0.5-10 mL containing 5-1000 ppb TNT in a phosphate-buffered saline buffer were preconcentrated in

180 ration of TT30 were unaffected by citrate or phosphate-buffered saline buffers and indicate an elonga

181 paB and 12 serum cytokines (p < or = .05 vs. phosphate-buffered saline challenge, except for interleu

182 et for 12 weeks, then administered rIL-19 or phosphate-buffered saline concomitant with Western diet

183 Cells suspended in phosphate-buffered saline consumed 2 mol of H2 per mol o

184 the HIV-1 RNA level in cervicovaginal fluid, phosphate-buffered saline containing 10 mM LiCl was used

185 An investigation of drug release kinetics in phosphate-buffered saline containing Tween 80 led us to

186 Afterwards, 5 x 10(5) CSCs (n = 30) or phosphate-buffered saline control (n = 15) was injected

187 dose of 20 mg/kg orally twice daily (n=7) or phosphate-buffered saline control (n=6) orally for 7 day

188 enge, 15 of 16 mice who were inoculated with phosphate-buffered saline developed lesions, one dose of

189 thymocytes, primary necrotic thymocytes, or phosphate-buffered saline did not.

190 hat were vaccinated with a control strain or phosphate-buffered saline died.

191 Conjugates injected subcutaneously in phosphate-buffered saline elicited immunoglobulin G (IgG

192 herent on a quartz substrate in a deuterated phosphate-buffered saline environment at room temperatur

193 ylate (100 mg/kg three times weekly) or with phosphate-buffered saline for 4 to 6 wk.

194 The aerosol particles were then dispersed in phosphate-buffered saline for cytotoxicity and senescenc

195 TNNB1-LNP), scrambled sequence (Scr-LNP), or phosphate-buffered saline for multiple cycles.

196 per day) into the right eyes in 20 rats and phosphate-buffered saline in 20 control rats was started

197 formed different complexes in serum than in phosphate-buffered saline in terms of both size and affi

198 ultipotent stem cells, or the same volume of phosphate-buffered saline in the peri-infarct area.

199 0 mM ribose in either serum ultrafiltrate or phosphate-buffered saline in the presence of various con

200 human amniotic mesenchymal stromal cells or phosphate-buffered saline infused intracerebroventricula

201 mucosa between the molars; and 6) group I-V: phosphate-buffered saline injected into the palatal muco

202 data with theoretical results suggests that phosphate-buffered saline is a good solvent for Q8 and Q

203 Mouse IgG diluted in phosphate-buffered saline is used as model target antige

204 assembly by injection from THF solution into phosphate-buffered saline led to unilamellar, monodisper

205 evels (i.e., 6-240 mg/dL) were quantified in phosphate-buffered saline medium using multivariate anal

206 e injected i.p. with 50 or 250 mg/kg APAP or phosphate-buffered saline on gestation day 12.5; nonpreg

207 was observed in control mice immunized with phosphate-buffered saline only.

208 individuals by the oral route, mice were fed phosphate-buffered saline or 10(6)M. canettii mycobacter

209 tal fat-derived stem/stromal cells in 50 muL phosphate-buffered saline or 50 muL phosphate-buffered s

210 dium was truncated by switching the cells to phosphate-buffered saline or by the addition of antibiot

211 Phosphate-buffered saline or iPSC-w/o-c-Myc was then int

212 anti-GXM died earlier than mice treated with phosphate-buffered saline or irrelevant isotype-matched

213 (OVA) at days 0 and 12, received intranasal phosphate-buffered saline or OVA challenges at days 24,

214 sensitized by intraperitoneal injections of phosphate-buffered saline or ovalbumin (OVA) at days 0 a

215 Formaldehyde, diluted in either phosphate-buffered saline or phosphate buffer, has been

216 addressed in murine airways challenged with phosphate-buffered saline or Pseudomonas aeruginosa.

217 e, which were challenged with OVA peptide or phosphate-buffered saline or remained untreated.

218 of BM cells and intramyocardial injection of phosphate-buffered saline rarely induced arrhythmias.

219 ily dissociated from the graft surface after phosphate-buffered saline rinsing.

220 properties of the water-soluble chlorins in phosphate-buffered saline solution (pH 7.4) at room temp

221 Mice that received phosphate-buffered saline solution only were included as

222 ide, and the ECL of the 1a film was found in phosphate-buffered saline solution with TPrA.

223 performed in both well-stirred and quiescent phosphate-buffered saline solutions as well as in a 0.3%

224 versibility of PRET upon the introduction of phosphate-buffered saline to the channel.

225 regulator PG490-88 (MRx-108; 0.75 mg/kg) or phosphate-buffered saline was administered preventilatio

226 tacept (CTLA4-Ig), etanercept (anti-TNF), or phosphate-buffered saline were given to NMRI mice intrav

227 o hundred thousand cells suspended in 20 muL phosphate-buffered saline were mixed with 200 muL Matrig

228 hat does not contain a transgene (Ad312) and phosphate-buffered saline were used as controls.

229 fied essential medium with 1.8 mm calcium or phosphate-buffered saline with 0.18 mm calcium have diff

230 er-resolution microscopy was demonstrated in phosphate-buffered saline without any reducing or oxidiz

231 to protofibrils or amyloid fibrils formed in phosphate-buffered saline without stirring at 37 degrees

232 Cys, a synthetic ligand of TLR2, or vehicle (phosphate-buffered saline) 24 h prior to Staphylococcus

233 the animals were compared to mock-immunized (phosphate-buffered saline) animals after bacterial chall

234 ion of infection compared to mock-immunized (phosphate-buffered saline) animals.

235 g/kg bodyweight intraperitoneal) or vehicle (phosphate-buffered saline) as control.

236 wth and prolonged median survival from 13 d (phosphate-buffered saline) to 20 and 29 d for DAR2 and D

237 day for five doses to one wound and vehicle (phosphate-buffered saline) to the other.

238 e IgG2alpha Fc fragment (Ad Fc), or vehicle (phosphate-buffered saline).

239 Median survival for the groups treated with phosphate-buffered saline, 6 MBq (213)Bi-IMP288, 12 MBq

240 omers enables robust cross-linking in water, phosphate-buffered saline, and cell culture medium to af

241 be delivered in a commercial moisturizer or phosphate-buffered saline, and do not require barrier di

242 temically administered (64)CuCl2 (74 MBq) or phosphate-buffered saline, and tumor sizes were monitore

243 d stability of these probes were assessed in phosphate-buffered saline, cell culture medium, rat seru

244 emotherapy alone, RF hyperthermia alone, and phosphate-buffered saline, combination therapy with RF h

245 emotherapy alone, RF hyperthermia alone, and phosphate-buffered saline, combination therapy with RF h

246 ation of 760+/-160 pM (120+/-25 ngml(-1)) in phosphate-buffered saline, falling to 2.5+/-0.7 nM (380+

247 nm and 25-30 nm, respectively, took place in phosphate-buffered saline, in sucrose solution, and in w

248 othelial cells, n = 4) or control treatment (phosphate-buffered saline, n = 4) by means of imaging-gu

249 nction 2 weeks after transplant (hCPC versus phosphate-buffered saline, P<0.03).

250 itro radiotracer stability was determined in phosphate-buffered saline, pH 7.4, and in challenge stud

251 99% radiochemical purity and were stable in phosphate-buffered saline, pH 7.4, for 24 h.

252 Biotinylated IgG was incubated with phosphate-buffered saline, plasma, or plasma treated to

253 (22.1 +/- 18.6% and 5.3 +/- 3.1%, for FG and phosphate-buffered saline, respectively).

254 of HCV(VLDF), compared with that mixed with phosphate-buffered saline, showing extracellular assembl

255 eceived an intracerebral injection of either phosphate-buffered saline, the neurotoxin saporin (SAP),

256 In whole lens isolated in phosphate-buffered saline, the spacing of the dominant X

257 lutathione-S-transferase (rGST)-adjuvant and phosphate-buffered saline-adjuvant served as nonvaccinat

258 s (6.1 +/- 0.5 %ID/cm(3)) when compared with phosphate-buffered saline-challenged animals (4.6 +/- 0.

259 tumor growth compared with mice treated with phosphate-buffered saline-containing liposomes (P<0.001)

260 28 days, compared with both sham-treated and phosphate-buffered saline-infused infarcted hearts, and

261 atment groups were compared with age-matched phosphate-buffered saline-injected control transgenic an

262 led animals receiving intravenous vehicle or phosphate-buffered saline-instilled animals receiving me

263 with parstatin compared to their respective phosphate-buffered saline-treated controls.

264 improve muscle regeneration, laminin-111 or phosphate-buffered saline-treated laminin-alpha2-deficie

265 antibody-treated animals lived, whereas 3/8 phosphate-buffered saline-treated mice died.

266 face atherosclerosis was noted compared with phosphate-buffered saline-treated mice.

267 creased hippocampal astrocytes compared with phosphate-buffered saline-treated rats, but displayed in

268 m 6TG-treated primary recipients relative to phosphate-buffered saline-treated recipients.

269 e in the rate of repair of the contralateral phosphate-buffered saline-treated wound when compared to

270 rly but increased later compared to those in phosphate-buffered saline-treated, PRCV-infected pigs, c

271 in all groups were agitated for 3 minutes in phosphate-buffered saline.

272 , nonpretargeted (177)Lu-IMP288 (60 MBq), or phosphate-buffered saline.

273 n 50 muL phosphate-buffered saline or 50 muL phosphate-buffered saline.

274 axane (25 mg/kg every other day, 3 doses) or phosphate-buffered saline.

275 /d), AG490, a JAK2 inhibitor (5 mg/kg/d), or phosphate-buffered saline.

276 d incubated with either 75 microM ammonia or phosphate-buffered saline.

277 incubating celecoxib and melanin in isotonic phosphate-buffered saline.

278 to the Con A concentration up to 10(-7) M in phosphate-buffered saline.

279 ith OVA, compared with controls treated with phosphate-buffered saline.

280 animal (RRV) or human (HAL1166) rotavirus or phosphate-buffered saline.

281 o bovine serum and in 9 days when exposed to phosphate-buffered saline.

282 in group 4 served as controls and were given phosphate-buffered saline.

283 ension of positive fecal and bile samples in phosphate-buffered saline.

284 eached as low as 3.5x10(1)CFUmL(-1) in 0.01M phosphate-buffered saline.

285 py alone, (c) RF hyperthermia alone, and (d) phosphate-buffered saline.

286 erapy only, (c) RF hyperthermia only, or (d) phosphate-buffered saline.

287 h; sham controls received an equal volume of phosphate-buffered saline.

288 ce treated with a scrambled-sequence PPMO or phosphate-buffered saline.

289 littermates received intraperitoneal nIgM or phosphate-buffered saline/bovine serum albumin/immunoglo

290 alone (200 million cells, n=5), or placebo (phosphate-buffered saline; n=5) was injected into the in

291 56days in various media: pH5.5, 6.5, and 7.4 phosphate buffered-saline (PBS) containing 0.02% Tween 8

292 The O2 concentrations in air-saturated phosphate-buffered salt solutions were monitored by meas

293 To demonstrate this analytical strategy, phosphate buffered serum albumin was spiked with carniti

294 immune deficiency virus) antibodies (Ab) in phosphate buffered solutions (PBS).

295 nt (kexp) found in both 1 mM NaHCO3 and 1 mM phosphate-buffered solutions suggested that OH radical w

296 re structure is compromised by mild aging in phosphate-buffered solutions, initiating mesopore collap

297 ate) (ABTS) and self-decay of ferrate(VI) in phosphate-buffered solutions.

298 Colloids in a pH 7 phosphate-buffered suspension show both higher sensitivi

299 on of an inert indium tin oxide electrode in phosphate-buffered water containing cobalt (II) ions.

300 and ferric chloride addition in borate- and phosphate-buffered waters showed that phosphate could se